462 related articles for article (PubMed ID: 6313596)
1. Acyclovir therapy of varicella-zoster virus infections in immunocompromised patients.
Balfour HH; McMonigal KA; Bean B
J Antimicrob Chemother; 1983 Sep; 12 Suppl B():169-79. PubMed ID: 6313596
[TBL] [Abstract][Full Text] [Related]
2. Comparison of acyclovir and vidarabine in immunocompromised children with varicella-zoster virus infection.
Kunitomi T; Akazai A; Ikeda M; Oda M; Kodani N
Acta Paediatr Jpn; 1989 Dec; 31(6):702-5. PubMed ID: 2516397
[TBL] [Abstract][Full Text] [Related]
3. Comparative trial of acyclovir and vidarabine in disseminated varicella-zoster virus infections in immunocompromised patients.
Vildé JL; Bricaire F; Leport C; Renaudie M; Brun-Vézinet F
J Med Virol; 1986 Oct; 20(2):127-34. PubMed ID: 3534140
[TBL] [Abstract][Full Text] [Related]
4. Current therapy of varicella zoster virus infection in immunocompromised patients. A comparison of acyclovir and vidarabine.
Shepp DH; Dandliker PS; Meyers JD
Am J Med; 1988 Aug; 85(2A):96-8. PubMed ID: 3044102
[TBL] [Abstract][Full Text] [Related]
5. Varicella-zoster virus infections in the immunocompromised host. Natural history and treatment.
Balfour HH
Scand J Infect Dis Suppl; 1991; 80():69-74. PubMed ID: 1666447
[TBL] [Abstract][Full Text] [Related]
6. Antiviral treatment in chickenpox and herpes zoster.
Huff JC
J Am Acad Dermatol; 1988 Jan; 18(1 Pt 2):204-6. PubMed ID: 3339143
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic approaches to varicella-zoster virus infections.
Whitley RJ
J Infect Dis; 1992 Aug; 166 Suppl 1():S51-7. PubMed ID: 1378081
[TBL] [Abstract][Full Text] [Related]
8. Antiviral therapy for varicella and herpes zoster.
Arvin AM
Semin Pediatr Infect Dis; 2002 Jan; 13(1):12-21. PubMed ID: 12118839
[TBL] [Abstract][Full Text] [Related]
9. Treatment of varicella-zoster virus infection in severely immunocompromised patients. A randomized comparison of acyclovir and vidarabine.
Shepp DH; Dandliker PS; Meyers JD
N Engl J Med; 1986 Jan; 314(4):208-12. PubMed ID: 3001523
[TBL] [Abstract][Full Text] [Related]
10. Natural history and treatment of varicella-zoster in high-risk populations.
Gnann JW; Whitley RJ
J Hosp Infect; 1991 Jun; 18 Suppl A():317-29. PubMed ID: 1679798
[TBL] [Abstract][Full Text] [Related]
11. Disseminated herpes zoster in the immunocompromised host: a comparative trial of acyclovir and vidarabine. The NIAID Collaborative Antiviral Study Group.
Whitley RJ; Gnann JW; Hinthorn D; Liu C; Pollard RB; Hayden F; Mertz GJ; Oxman M; Soong SJ
J Infect Dis; 1992 Mar; 165(3):450-5. PubMed ID: 1538151
[TBL] [Abstract][Full Text] [Related]
12. [Acyclovir therapy in varicella/zoster diseases in immunocompromised children with cancer].
Kuhn N; Landbeck G
Monatsschr Kinderheilkd; 1984 Feb; 132(2):105-9. PubMed ID: 6328285
[TBL] [Abstract][Full Text] [Related]
13. Current management of varicella zoster virus infections.
Balfour HH
J Med Virol; 1993; Suppl 1():74-81. PubMed ID: 8245897
[TBL] [Abstract][Full Text] [Related]
14. Continuous varicella-zoster infection associated with acyclovir resistance in a child with AIDS.
Pahwa S; Biron K; Lim W; Swenson P; Kaplan MH; Sadick N; Pahwa R
JAMA; 1988 Nov; 260(19):2879-82. PubMed ID: 3184352
[TBL] [Abstract][Full Text] [Related]
15. Utility of ultra-deep sequencing for detection of varicella-zoster virus antiviral resistance mutations.
Mercier-Darty M; Boutolleau D; Lepeule R; Rodriguez C; Burrel S
Antiviral Res; 2018 Mar; 151():20-23. PubMed ID: 29337163
[TBL] [Abstract][Full Text] [Related]
16. Management of acyclovir-resistant herpes simplex and varicella-zoster virus infections.
Balfour HH; Benson C; Braun J; Cassens B; Erice A; Friedman-Kien A; Klein T; Polsky B; Safrin S
J Acquir Immune Defic Syndr (1988); 1994 Mar; 7(3):254-60. PubMed ID: 8106965
[TBL] [Abstract][Full Text] [Related]
17. Early relapses of varicella-zoster virus infection in immunocompromised children treated with acyclovir.
Mészner Z; Gyarmati E; Nyerges G; Simon M; Koller M
Acta Paediatr Hung; 1990; 30(2):263-70. PubMed ID: 2248805
[TBL] [Abstract][Full Text] [Related]
18. Clinical course and therapeutic approach to varicella zoster virus infection in children with rheumatic autoimmune diseases under immunosuppression.
Leuvenink R; Aeschlimann F; Baer W; Berthet G; Cannizzaro E; Hofer M; Kaiser D; Schroeder S; Heininger U; Woerner A
Pediatr Rheumatol Online J; 2016 Jun; 14(1):34. PubMed ID: 27256096
[TBL] [Abstract][Full Text] [Related]
19. Varicella zoster virus infections in immunocompromised hosts. A review of the natural history and management.
Balfour HH
Am J Med; 1988 Aug; 85(2A):68-73. PubMed ID: 3044096
[TBL] [Abstract][Full Text] [Related]
20. Treatment of herpesvirus infections in the immunocompromised host.
Meyers JD
Scand J Infect Dis Suppl; 1985; 47():128-36. PubMed ID: 2419973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
